Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
4
self-reported 2–10 band
Founded
2016
10 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
A new evergreen open-ended global fund investing in Health, Agricultural biotechnology and Industrial biotechnology companies.
Unique Fund Structure
- Evergreen, open-ended Fund enabling continuous and flexible deal flow
- No sunset date or cap on the value of the fund
- Geography-agnostic investments
- Ongoing capital and strategic support for investments
- Management remuneration aligned to investors’ interests
- Tax neutral location and tax-effective arrangements at all levels
- Bespoke structure for significant investors with long-term horizon
Maximise Investment Returns
- Robust process for investment selection
- Active ongoing involvement with investee companies to manage risk and maximise return
- Income flows directly to investors
- Flexible reinvestment pathways
Investments That Make a Difference
- The Fund invests in innovative and disruptive technologies in the biotech space – medical, agricultural, industrial
- High growth diversified international later stage investments
- Investments that matter to people because they make lives better or improve society as a whole
- Measurable impact quantified by internationally accredited organisations
- Built through alliances and collaborations with strategic partners, such as pharmaceutical companies, medical research institutes and universities and clinical research and manufacturing organisations
First Class Management Team
- Experienced team with global networks and track record in commercialisation, licencing, fund development and investment management across Asia, Europe and North America
- Managed from Australia, with satellite offices located in strategic geographies
Specialties
All 7 specialties
- Investment Management
- Medical devices and diagnostics
- Biotechnology
- Health Digital/IT
- Agricultural biotechnology
- Industrial biotechnology
- Fund management
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AULevel 13, 10 Queens Rd; Melbourne, Victoria 3004Primary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at this brand?
The record holds 4 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does this brand have offices?
One address on record, Australia only. Primary: Level 13, 10 Queens Rd, Melbourne, Victoria 3004.
Has this brand raised funding?
None linked to this brand.
What does this brand list as its specialties?
Seven tags on the brand's own list, among them investment management, biotechnology and fund management.
Which companies are listed alongside this brand?
2 profiles list Bio Capital Impact Fund - investing in what matters for life as a peer. It lists ten peers of its own. Madson Group and AgCrowd (Acquired in 2019) list it back.